Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 20/20 | 0.56 |
| ▸ | CCNE1 | P24864 | 4/20 | 0.56 |
| ▸ | CDK1 | P06493 | 3/20 | 0.56 |
| ▸ | CCNB1 | P14635 | 3/20 | 0.56 |
| ▸ | CDK6 | Q00534 | 16/20 | 0.46 |
| ▸ | CCND1 | P24385 | 6/20 | 0.46 |
| ▸ | CCND3 | P30281 | 6/20 | 0.46 |
| ▸ | CDK2 | P24941 | 10/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18288744 | 0.86 | CDK4 (0.55) | CDK4CCNE1CDK1CCNB1CDK6 | |
| SCHEMBL18288760 | 0.86 | CDK4 (0.55) | CDK4CCNE1CDK1CCNB1CDK6 | |
| SCHEMBL18288902 | 0.85 | CDK4 (0.56) | CDK4CCNE1CDK1CCNB1CDK6 | |
| SCHEMBL18288742 | 0.82 | CDK4 (0.45) | CDK4CCNE1CDK1CCNB1CDK6 | |
| SCHEMBL31066374 | 0.76 | CDK4 (0.54) | CDK4CCNE1CDK1CCNB1CDK6 | |
| SCHEMBL15252502 | 0.76 | CDK4 (0.54) | CDK4CCNE1CDK1CCNB1CDK6 | |
| SCHEMBL18288796 | 0.75 | CDK4 (0.56) | CDK4CCNE1CDK1CCNB1CDK6 | |
| SCHEMBL19089070 | 0.74 | CDK4 (0.55) | CDK4CCNE1CDK1CCNB1CDK6 | |
| SCHEMBL18823109 | 0.74 | CDK4 (0.56) | CDK4CCNE1CDK1CDK6CCND3 | |
| SCHEMBL29402856 | 0.73 | CDK4 (0.55) | CDK4CCNE1CDK1CCNB1CDK6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016192630-A1 | COMPOUND HAVING KINASE INHIBITING ACTIVITY, METHOD OF PREPARING SAME, AND USE OF SAME | 中国科学院上海药物研究所 | 2016-12-08 | — | — | WO | disclosed |